Company · CIK 1652724
Lucira Health, Inc.
| CIK | 1652724 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2835 — In Vitro & In Vivo Diagnostic Substances |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-03-31 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-252164 | 2021-01-15 | 2021-02-08 | 4 |
Filings
5| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2021-02-08 | 424B4Final prospectus | 333-252164 | 0001193125-21-031881 |
| 2021-02-04 | EFFECTDeclared effective | 333-252164 | 9999999995-21-000444 |
| 2021-02-01 | S-1/AAmendment | 333-252164 | 0001193125-21-023778 |
| 2021-01-15 | S-1Registration filed | 333-252164 | 0001193125-21-010174 |
| 2020-11-23 | DRSDraft made public | 377-03812 | 0000950123-20-012335 |